HB Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
17,289
+721
+4% +$66.2K 0.01% 505
2025
Q4
$1.49M Sell
16,568
-1,140
-6% -$108K 0.01% 499
2025
Q3
$1.74M Buy
17,708
+1,537
+10% +$152K 0.01% 445
2025
Q2
$1.48M Sell
16,171
-2,857
-15% -$276K 0.01% 440
2025
Q1
$2.15M Buy
19,028
+14,726
+342% +$1.58M 0.02% 363
2024
Q4
$455K Buy
4,302
+241
+6% +$25.9K ﹤0.01% 651
2024
Q3
$438K Buy
4,061
+197
+5% +$21.5K ﹤0.01% 629
2024
Q2
$419K Buy
3,864
+107
+3% +$12.6K ﹤0.01% 596
2024
Q1
$496K Buy
3,757
+400
+12% +$50K 0.01% 505
2023
Q4
$409K Buy
3,357
+774
+30% +$86.4K 0.01% 513
2023
Q3
$290K Sell
2,583
-163
-6% -$20.7K ﹤0.01% 579
2023
Q2
$400K Buy
2,746
+182
+7% +$24.7K 0.01% 474
2023
Q1
$331K Buy
2,564
+193
+8% +$24.2K 0.01% 508
2022
Q4
$302K Buy
2,371
+92
+4% +$10.7K 0.01% 512
2022
Q3
$238K Sell
2,279
-172
-7% -$18.9K 0.01% 497
2022
Q2
$258K Buy
2,451
+585
+31% +$69.4K 0.01% 477
2022
Q1
$239K Buy
+1,866
New +$225K ﹤0.01% 516

Other funds holding ZBH

HB Wealth Management's ZBH Position: Q1 2026 in Review

HB Wealth Management increased its Zimmer Biomet (ZBH) stake by 4.4% in Q1 2026, buying an estimated $66.2K and bringing the position to 17,289 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #505.

HB Wealth Management first reported a position in ZBH in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.15M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • HB Wealth Management held 17,289 shares of Zimmer Biomet worth $1.56M as of Q1 2026.
  • HB Wealth Management bought 721 Zimmer Biomet shares in Q1 2026, an estimated $66.2K.
  • Zimmer Biomet made up 0.01% of HB Wealth Management's portfolio in Q1 2026, its #505 holding.
  • HB Wealth Management first reported a position in Zimmer Biomet in Q1 2022 and has held it in 17 quarters since.
  • HB Wealth Management's Zimmer Biomet position peaked at $2.15M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.